Melanoma patients in a phase I clinic: molecular aberrations, targeted therapy and outcomes

BACKGROUND: The purpose of the study was to assess the outcome of patients with advanced melanoma treated with matched molecularly targeted therapy. PATIENTS AND METHODS: We reviewed 160 consecutive patients with metastatic melanoma treated in the phase I program (N = 35 protocols). Treatment was co...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Henary, H., Hong, D. S., Falchook, G. S., Tsimberidou, A., George, G. C., Wen, S., Wheler, J., Fu, S., Naing, A., Piha-Paul, S., Janku, F., Kim, K. B., Hwu, P., Kurzrock, R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2013
Konular:
original articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4081655/
https://ncbi.nlm.nih.gov/pubmed/23576709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt115
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller